Aggregate Spend
AGGREGATE SPEND ARTICLES
-
![GettyImages-1168967788_cancer group therapy]( "Oncolytic Virus Therapy: Insights Into Clinical Trial Landscape And Industry Trends")
Oncolytic Virus Therapy: Insights Into Clinical Trial Landscape And Industry TrendsAnswering questions about the potential of oncolytic virus therapies, how they integrate with combination therapies, the regulatory landscape, and how it varies globally.
AGGREGATE SPEND SOFTWARE WHITE PAPERS AND CASE STUDIES
-
![GettyImages-893884852 doctors tablet data]( "eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality")
eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data QualityDiscover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.
-
![GettyImages-2024513353 drug manufacturing]( "Comparative Analysis Of Batch And Continuous Processes")
Comparative Analysis Of Batch And Continuous ProcessesExplore a comparative analysis that showcases the superior performance of continuous processing over traditional batch methods, highlighting key improvements in efficiency and environmental impact.
-
![Port Washington Wastewater Treatment Plant]( "The Savings Are Blowin' In At Port Washington Wastewater Treatment Plant")
The Savings Are Blowin' In At Port Washington Wastewater Treatment PlantThe municipal wastewater treatment plant in Port Washington, Wisconsin, is located on the picturesque shore of Lake Michigan, so it’s essential that their plant performs as designed.
AGGREGATE SPEND PRODUCTS
A comprehensive solution for water quality testing with integrated data intelligence.
Specialization in the pre-assembly of glass syringes (glass barrel with cannula) as well as final assembly and material handling.
ODiate Fluorescence Filter Sets are designed to meet the demanding requirements of fluorescence and microscopy applications.
The VMS1197B magnetron is a high-power microwave oscillator in which the potential energy of an electron cloud near the cathode is converted into RF energy in a series of cavity resonators. This 750 kW magnetron operates within the 2.7 – 2.9 (S-band) GHz frequency range and delivers high peak and average RF power for use in weather, medical, or industrial applications.
The ADM-9181PSM is a versatile distributed amplifier designed for wideband operation from 100 MHz to 22 GHz.
The DecFill LM-200 and DecFill LM-560 are compact, fully automatic labeling machines designed for the automated labeling of vials, bottles, syringes, ampules, cartridges, and other containers with self-adhesive labels.
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.
The ADM-9027CH is a wideband distributed low noise amplifier capable of providing 16 dB gain and +25 dBm OIP3 from 2 to 20 GHz and a low 2.5 dB typical noise figure from 7 to 18 GHz.
AGGREGATE SPEND SOFTWARE NEWS
-
Baden-Württemberg's Largest Solar Park Now In Operation5/28/2025
EnBW has commissioned its solar park in Langenenslingen-Wilflingen (district of Biberach in the southwest of Germany).
-
Anritsu Supports Evaluation Of 5G NR NTN Devices For Satellite-Based Communications7/29/2025
Anritsu Corporation, a global leader in test and measurement solutions, is pleased to announce that its Radio Communication Test Station MT8000A, a measurement solution for 5G devices such as smartphones, now supports evaluation of 5G NR NTN devices for non-terrestrial networks (NTN), which enables communication via satellite.
-
Consulta Remedios Selects Kevel's Retail Media Cloud To Power Its Next-Generation Advertising Platform5/2/2025
Kevel, the leading provider of API-based retail media ad serving technology, today announced that Consulta Remédios, Brazil's largest medicine price comparison platform, has selected Kevel's Retail Media Cloud to power the development and enhancement of its in-house retail media network.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
How Lakes Connect To Groundwater Critical For Resilience To Climate Change7/9/2025
The study drew on data from 350 lakes across 18 European countries, collected between 2022 and 2024, to provide a comprehensive picture of how the continent’s lakes are coping with climate change.
ABOUT
Aggregate Spend
Aggregate Spend refers to the process used to aggregate and monitor the total amount spent on organizations and individual healthcare professionals by healthcare manufacturers. The amount spent is aggregated in terms of payments made, honoraria, gifts, travel and other means. Aggregate spend is also known as the Physician Spend Sunshine Law which is an initiative that is aimed to achieve transparency in life sciences industry, the benefits of each physician as well as to limit spend per physician. The law is a body of state and federal legislations. Passing of this law was also in effort to alleviate the conflicts of interest between pharmaceutical and medical device companies and healthcare professionals.
The process requires that manufactures of various medical devices, drugs, biological and other supplies recorded all payments made to physicians including any other transfers of value to teaching hospitals and physicians. Report regarding all this information is required to be produced annually by all the applicable manufacturers and suppliers. The manufacturers are required to include details such as date, nature of payment and the value. Penalties are charged in case of breaching this law by the target parties.
By doing this, accountability of individual physicians and medical device, pharmaceutical and life sciences companies can be achieved. The challenge now is to the life science companies to address the reporting requirements and more so now that state and federal regulatory agency continue to enact legislation that require more auditing of monetary transactions to physicians and organizations involved in healthcare management. As a result many companies are now working more diligently to address compliance and gain more competitive advantage through reputation management among other ways.